Description
Developer of prescription products intended for aesthetic dermatology. The company's products focus on the treatment of wrinkles, primary axillary hyperhidrosis, androgenic alopecia, and hair greying, thereby enabling patients to get rid of problems like lateral canthal lines.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Early Stage VC (Series A) | 09-Mar-2021 | $43M | 0000 | Completed | Clinical Trials - Phase 2 | |
1. Spin-Off | 01-Jan-2016 | Completed | Startup |
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
000 000000 | Corporate Backed or Acquired | Charleston, SC | 000 | 00.000 | 000000&0 |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2020274082-A1 | Delaying peak effect and/or extending duration of response | Pending | 14-May-2019 | 0000000000 | |
CA-3139983-A1 | Delaying peak effect and/or extending duration of response | Pending | 14-May-2019 | 0000000000 | |
EP-3969038-A1 | Delaying peak effect and/or extending duration of response | Pending | 14-May-2019 | 0000000000 | |
US-20220296503-A1 | Delaying peak effect and/or extending duration of response | Pending | 14-May-2019 | 00000000000 | |
AU-2019391791-A1 | Improved delivery of large agents | Pending | 03-Dec-2018 | A61K8/66 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jon Edelson MD | Founder, Chief Executive Officer, Chairman & President | ||
Ron Goldstein | Chief Financial Officer | ||
Klaus Theobald Ph.D | Chief Research & Development Officer |
Name | Representing | Role | Since |
---|---|---|---|
Albert Hummel | Self | Board Member | 000 0000 |
Barry Kurokawa | Self | Board Member | 000 0000 |
Carter Meyer JD | Self | Board Member | 000 0000 |
Jon Edelson MD | Eirion | Founder, Chief Executive Officer, Chairman & President | 000 0000 |
Kevin Finney | Self | Vice Chairman | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Gore Range Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Shanghai Hao Hai Healthcare | Corporation | Minority | 000 0000 | 000000 0 | |
Praesideo Management | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Scientific Health Development | Venture Capital | Minority | 000 0000 | 000000 0 | |
The Spring Bay Companies | Venture Capital | Minority | 000 0000 | 000000 0 |